The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 02, 2021

Filed:

Apr. 09, 2019
Applicant:

Sarepta Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Patrick L. Iversen, Corvallis, OR (US);

Hong M. Moulton, Corvallis, OR (US);

Michelle H. Nelson, Corvallis, OR (US);

David A. Stein, Corvallis, OR (US);

Andrew D. Kroeker, Cambridge, MA (US);

Assignee:

Sarepta Therapeutics, inc., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 47/64 (2017.01); A61K 49/00 (2006.01); C12N 15/87 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0056 (2013.01); A61K 47/64 (2017.08); A61K 49/0043 (2013.01); A61K 49/0054 (2013.01); C12N 15/113 (2013.01); C12N 15/87 (2013.01); C12N 2310/11 (2013.01); C12N 2310/314 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/3513 (2013.01); C12N 2320/32 (2013.01);
Abstract

Compositions and methods for enhancing delivery of molecules, e.g. biological agents, into cells are described. The composition is a conjugate of the biological agent, preferably a nucleic acid analog having a substantially uncharged backbone, covalently linked to a peptide transporter moiety as described. Conjugation of the peptide transporter to a substantially uncharged nucleic acid analog, such as a morpholino oligomer, is also shown to enhance binding of the oligomer to its target sequence and enhance antisense activity.


Find Patent Forward Citations

Loading…